Skip to main content
. 2012 Mar;88(3):260–268. doi: 10.1111/j.1600-0609.2011.01726.x

Fig. 2.

Fig. 2

Median serum ferritin levels (±25th and 75th percentiles) and mean daily dose over 12 months in patients with myelodysplastic syndromes who were (A) prechelated and (B) chelation-naïve.